Sledovat
Xavier Montalban
Xavier Montalban
Neznámá organizace
E-mailová adresa ověřena na: cem-cat.org
Název
Citace
Citace
Rok
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
CH Polman, SC Reingold, B Banwell, M Clanet, JA Cohen, M Filippi, ...
Annals of neurology 69 (2), 292-302, 2011
109332011
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
AJ Thompson, BL Banwell, F Barkhof, WM Carroll, T Coetzee, G Comi, ...
The Lancet Neurology 17 (2), 162-173, 2018
67472018
Defining the clinical course of multiple sclerosis: the 2013 revisions
FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ...
Neurology 83 (3), 278-286, 2014
37542014
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Nature 476 (7359), 214-219, 2011
29842011
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis
JA Cohen, F Barkhof, G Comi, HP Hartung, BO Khatri, X Montalban, ...
New England Journal of Medicine 362 (5), 402-415, 2010
28172010
Ocrelizumab versus placebo in primary progressive multiple sclerosis
X Montalban, SL Hauser, L Kappos, DL Arnold, A Bar-Or, G Comi, ...
New england journal of medicine 376 (3), 209-220, 2017
19172017
Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis
SL Hauser, A Bar-Or, G Comi, G Giovannoni, HP Hartung, B Hemmer, ...
New England Journal of Medicine 376 (3), 221-234, 2017
18292017
Oral fingolimod (FTY720) for relapsing multiple sclerosis
L Kappos, J Antel, G Comi, X Montalban, P O'Connor, CH Polman, T Haas, ...
New England Journal of Medicine 355 (11), 1124-1140, 2006
13262006
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity
R Roxburgh, SR Seaman, T Masterman, AE Hensiek, SJ Sawcer, ...
Neurology 64 (7), 1144-1151, 2005
10672005
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
M Filippi, MA Rocca, O Ciccarelli, N De Stefano, N Evangelou, L Kappos, ...
The Lancet Neurology 15 (3), 292-303, 2016
10442016
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes
L Kappos, CH Polman, MS Freedman, G Edan, HP Hartung, DH Miller, ...
Neurology 67 (7), 1242-1249, 2006
10212006
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ...
The Lancet 391 (10127), 1263-1273, 2018
9662018
Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis
D Miller, F Barkhof, X Montalban, A Thompson, M Filippi
The Lancet Neurology 4 (5), 281-288, 2005
9492005
Differential diagnosis of suspected multiple sclerosis: a consensus approach
DH Miller, BG Weinshenker, M Filippi, BL Banwell, JA Cohen, ...
Multiple Sclerosis Journal 14 (9), 1157-1174, 2008
9312008
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis
X Montalban, R Gold, AJ Thompson, S Otero-Romero, MP Amato, ...
Multiple Sclerosis Journal 24 (2), 96-120, 2018
9272018
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
International Multiple Sclerosis Genetics Consortium*†, ANZgene, ...
Science 365 (6460), eaav7188, 2019
8982019
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind …
G Comi, V Martinelli, M Rodegher, L Moiola, O Bajenaru, A Carra, ...
The Lancet 374 (9700), 1503-1511, 2009
7872009
Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the …
L Kappos, MS Freedman, CH Polman, G Edan, HP Hartung, DH Miller, ...
The Lancet 370 (9585), 389-397, 2007
7342007
Vitamin D as an early predictor of multiple sclerosis activity and progression
A Ascherio, KL Munger, R White, K Köchert, KC Simon, CH Polman, ...
JAMA neurology 71 (3), 306-314, 2014
6812014
Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis
M Tintoré, A Rovira, MJ Martínez, J Rio, P Díaz-Villoslada, L Brieva, ...
American Journal of Neuroradiology 21 (4), 702-706, 2000
6742000
Systém momentálně nemůže danou operaci provést. Zkuste to znovu později.
Články 1–20